Lysozyme release and polymer erosion behavior of injectable implants prepared from plga-peg block copolymers and plga/plga-peg blends

Pharmaceutical Research

Volumn 31, Issue 2, 2014, Pages 436-448

  Milacic, Vesna ^a   Schwendeman, Steven P ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

controlled release; implants; lysozyme; PLGA PEG block co polymers

Indexed keywords

COPOLYMER; LYSOZYME; MACROGOL; POLYGLACTIN; POLYSORBATE 80;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DEGRADATION; DEGRADATION KINETICS; DRUG EFFECT; DRUG SCREENING; ENCAPSULATION; IN VITRO STUDY; INJECTABLE IMPLANT; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN SECRETION; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; WATER TRANSPORT;

DELAYED-ACTION PREPARATIONS; EXCIPIENTS; INJECTIONS; KINETICS; LACTIC ACID; MOLECULAR WEIGHT; MURAMIDASE; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS; PROSTHESES AND IMPLANTS; SOLVENTS; WATER;

EID: 84896722733     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1173-6     Document Type: Article

References (30)

1. Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm. 2008;364(2):298-327.
2. Milacic V, Bailey BA, O'Hagan D, Schwendeman SP. Injectable PLGA Systems for Delivery of Vaccine Antigens. In: Advances in Delivery Science and Technology: Long Acting Implants and Injections, Springer (New York, NY 10013, USA), 429-458, 2012. (Book chapter).
3. Ding AG, Shenderova A, Schwendeman SP. Prediction of microclimate pH in poly(lactic-co-glycolic acid) films. J Am Chem Soc. 2006;128(16):5384-90.
4. Putney SD, Burke PA. Improving protein therapeutics with sustained-release formulations. Nat Biotechnol. 1998;16(2):153-7.
5. Schwendeman SP. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Crit Rev Ther Drug Carrier Syst. 2002;19(1):73-98.
6. Jiang W, Gupta RK, Deshpande MC, Schwendeman SP. Adv Drug Deliv Rev. 2005;57:391-410.
7. Zhu GZ, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nat Biotechnol. 2000;18(1):52-7.
8. Zhu GZ, Schwendeman SP. Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives. Pharm Res. 2000;17(3):351-7.
9. Lavelle EC, Yeh MK, Coombes AG, Davis SS. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Vaccine. 1999;17:512-29.
10. Jiang WL, Schwendeman SP. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L-lactide) and poly(ethylene glycol) microsphere blends. Pharm Res. 2001;18(6):878-85.
11. Liu WR, Langer R, Klibanov AM. Moisture-induced aggregation of lyophilized proteins in the solid state. Biotech Bioeng. 1991;37(2):177-84.
12. Jeong JH, Lim DW, Han DK, Park TG. Synthesis, characterization and protein adsorption behaviors of PLGA:PEG di-block co-polymer blend films. Colloids Surf B: Biointerfaces. 2000;18:371-9.
13. Kissel T, Li YX, Volland C, Gorich S, Koneberg R. Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks. J Control Release. 1996;39(2-3):315-26.
14. Kissel T, Li YX, Unger F. ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins. Adv Drug Deliv Rev. 2002;54(1):99-134.
15. Kang JC, Schwendeman SP. Comparison of the effects of Mg(OH)(2) and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(D, L-lactide-co-glycolide) implants. Biomaterials. 2002;23(1):239-45.
16. Bittner B, Witt C, Mäder K, Kissel T. Degradation and protein release properties of microspheres prepared from biodegradable poly(lactide-co-glycolide) and ABA triblock copolymers: influence of buffer media on polymer erosion and bovine serum albumin release. J Control Release. 1999;60(2-3):297-309.
17. Luan X, Bodmeier R. Modification of the tri-phasic drug release pattern of leuprolide acetate-loaded poly(lactide-co-glycolide) microparticles. Eur J Pharm Biopharm. 2006;6:205-14.
18. Witt C, Kissel T. Morphological characterization of microspheres, films and implants prepared from poly(lactide-co-glycolide) and ABA triblock copolymers: is the erosion controlled by degradation, swelling or diffusion? Eur J Pharm Biopharm. 2001;51(3):171-81.
19. Wang J, Wang BA, Schwendeman SP. Characterization of the initial burst release of a model peptide from poly(d, llactide-co-glycolide) microspheres. J Control Release. 2002;82:289-307.
20. Kang J, Schwendeman SP. Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins. Mol Pharm. 2007;4(1):104-18.
21. Cui C, Stevens VC, Schwendeman SP. Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine. Vaccine. 2007;25(3):500-9.
22. Jiang W, Schwendeman SP. Stabilization of tetanus toxoid encapsulated in PLGA microspheres. Mol Pharm. 2008;5(5):808-17.
23. Zhong Y, Zhang L, Ding AG, Shenderova A, Zhu G, Pei P, et al. Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/Poly(DL-lactic-co- glycolic acid) implants. J Control Release. 2007;122:331-7.
24. Bernstein H, Zhang Y, Khan AM, Tracy MA. Modulated release from biodegradable polymers, US patent# 5,656,297, 1997. http://patft.uspto.gov/ netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u= %2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d= PTXT&s1=5656297.PN.&OS=PN/5656297&RS=PN/5656297.
25. Hrkach JS, Peracchia MT, Domb A, Lotan N, Langer R. Nanotechnology for biomaterials engineering: structural characterization of amphiphilic polymeric nanoparticles by 1H NMR spectroscopy. Biomaterials. 1997;18(1):27-30.
26. Li YX, Kissel T. Synthesis and properties of biodegradable ABA triblock copolymers consisting of poly(L-lactic acid) or poly(L-lactic-co-glycolic acid) A-blocks attached to central poly(oxyethylene) B-blocks. J Control Release. 1993;27:247-57.
27. Schein CH. Solubility as a function of protein structure and solvent components. Biotechnology. 1990;8:308-17.
28. Jeon SI, Lee JH, Andrade JD, De Gennes PG. Protein - surface interactions in the presence of polyethylene oxide: I. Simplified theory. J Colloid Interface Sci. 1991;142(1):149-58.
29. Desai KGH, Mallery SR, Schwendeman SP. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co- glycolide) implants. Eur J Pharm Biopharm. 2008;70:187-98.
30. Kenley RA, Lee MO, Mahoney II TR, Sanders LM. Poly(lactide-co-glycolide) decomposition kinetics in vivo and in vitro. Macromolecules. 1987;20(10):2398-403.